Navigation Links
The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer
Date:7/23/2008

- Nexavar is First Approved Systemic Therapy to Treat the Disease -

WAYNE, N.J. and EMERYVILLE, Calif., July 23 /PRNewswire-FirstCall/ -- Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced that The New England Journal of Medicine published results of a Phase 3 trial demonstrating that Nexavar(R) (sorafenib) tablets decreased the absolute risk of death by 31 percent in patients with unresectable hepatocellular carcinoma (HCC), or liver cancer, versus patients who received placebo. This represents a 44 percent improvement in median overall survival for patients treated with Nexavar.

Based on the strength of these data, Nexavar was approved for HCC by the European Agency for the Evaluation of Medicinal Products (EMEA) and by the U.S. Food and Drug Administration (FDA) in October and November 2007, respectively.

"Despite advances in the management of many other cancers, liver cancer has remained a treatment challenge, due to a lack of systemic therapies to extend life and limited opportunity for surgical intervention," said Dr. Josep M. Llovet, co-principal investigator of the study and professor of research, Barcelona Clinic Liver Cancer (BCLC) Group, IDIBAPS, Liver Unit, Hospital Clinic Barcelona; director of research, HCC Program, associate professor of Medicine, Mount Sinai School of Medicine, New York. "This landmark study reflects a new systemic standard of care using Nexavar in the first-line management of liver cancer."

"The number of lives lost to liver cancer continues to increase globally, due to the prevalence of hepatitis B and C infections," said Jordi Bruix, co-principal investigator and director of the Barcelona Clinic Liver Cancer (BCLC) Group; senior consultant, Liver Unit, Hospital Clinic of Barcelona. "We are encouraged that there is a new treatment option available for liver cancer that has clearly demonstrated a survival benefit in this patient population."

The in
'/>"/>

SOURCE Bayer HealthCare Pharmaceuticals; Onyx Pharmaceuticals,Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. The New England Journal of Medicine Publishes Study Investigating the Safety and Efficacy of Baxters Cell-Based Pandemic, Avian Flu Vaccine
2. New England Journal of Medicine Publishes Results From a RELISTOR Phase 3 Clinical Study
3. Berkery Noyes Represented The Thomson Corporation in the Sale of CenterWatch and New England Institutional Review Board to Jobson Medical Information
4. New England Journal of Medicine Study Shows ERBITUX(R) Improves Survival in Advanced Colorectal Cancer
5. The New England Journal of Medicine Publishes First Clinical Results for MedImmunes Chitinase-like Protein YKL-40 in Patients With Asthma
6. Studies Showing Significant Survival Improvement with Taxotere(R)-based Regimens in the Induction Treatment of Patients with Locally Advanced Head and Neck Cancer are Published in the Same Issue of the New England Journal of Medicine
7. Vaccine Study in New England Journal of Medicine Wrong in Concluding Mercury Exposures are Harmless, States SafeMinds
8. Results from Study Evaluating PROCRIT(R) in Intensive Care Unit Patients Published in New England Journal of Medicine
9. Bioimpedance Spectroscopy is More Accurate and Reliable Than Other Methods of Subclinical Assessment of Lymphedema in Breast Cancer Patients, According to Paper Published in Journal of Clinical Oncology
10. Groundbreaking American Journal of Play from Strong National Museum of Play(R) Premiers July 2008
11. Journal of Clinical Oncology Publishes Study of Cephalon Medication TREANDA Plus Rituximab in Relapsed Non-Hodgkins Lymphoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... Valeant Pharmaceuticals International, Inc. (NYSE: ... company,s Bridgewater, New Jersey location ... Drug Administration (FDA) relating to an inspection in June ... Aesthetic injectable, which was divested to Galderma S.A. in ... Valeant,s contract manufacturers (rather than Valeant,s own internal manufacturing) ...
(Date:9/30/2014)... MOUNTAIN VIEW, Calif. , Sept. 30, 2014 /PRNewswire/ ... today, which integrates with HealthKit in iOS 8 and ... with their doctors. The app harnesses native iOS technologies ... patients to maintain a robust connection with their doctors ... wearable health devices and the data they collect is ...
(Date:9/30/2014)... Sept. 30, 2014  Based on its recent ... & Sullivan recognizes Ventana Medical Systems, Inc. (Ventana), ... 2014 North American Frost & Sullivan Award for ... along with a focus on innovation and improving ... in tissue-based cancer diagnostic solutions for patients worldwide. ...
Breaking Medicine Technology:Valeant Pharmaceuticals' Bridgewater Location Receives Warning Letter From FDA 2HealthLoop Integrates with Apple's HealthKit Enabling Patients to Share Health Data with Their Doctors Right from their iPhone 2Frost & Sullivan applauds the diversity of Ventana products and services for the cancer diagnostics market 2Frost & Sullivan applauds the diversity of Ventana products and services for the cancer diagnostics market 3Frost & Sullivan applauds the diversity of Ventana products and services for the cancer diagnostics market 4
... Neb., May 15 Creighton Medical Laboratories, based at ... announced today that it has become the first clinical ... testing method for cancer. The method, called SNP array ... to study cancer for several years. However, Creighton Medical ...
... Case Demonstrating RenalGuard To Be PresentedFRANKLIN, Mass., May ... PLCSF), a company focused on innovative cardiac and ... will demonstrate its RenalGuard System(TM) at EuroPCR, the ... Cardiovascular Interventions (EAPCI), May 19-22, 2009, in Barcelona, ...
Cached Medicine Technology:Creighton Medical Laboratories First to Offer New Cancer Test 2Creighton Medical Laboratories First to Offer New Cancer Test 3PLC Medical Systems to Demonstrate RenalGuard(R) at EuroPCR 2009 2PLC Medical Systems to Demonstrate RenalGuard(R) at EuroPCR 2009 3PLC Medical Systems to Demonstrate RenalGuard(R) at EuroPCR 2009 4
(Date:9/30/2014)... (PRWEB) September 30, 2014 Visit Pam ... Chestnut Hill and you will find a loving couple ... Amyotrophic Lateral Sclerosis. , Steve was diagnosed ... Lou Gehrig’s Disease – just before the couple’s second ... caregiver. , A new video, “Care, Support & ...
(Date:9/30/2014)... (PRWEB) September 30, 2014 Edward D. ... Plastic Surgery, has been approved to be a director ... Plastic and Reconstructive Surgery (AAFPRS) fellowship program. The announcement ... in Orlando, Florida. , The Educational and Research Foundation ... medical community. It represents the finest postgraduate program in ...
(Date:9/30/2014)... (PRWEB) September 30, 2014 Neuromuscular ... people throughout the United States and worldwide. It ... Disease are diagnosed each year, adding to the ... the disease. Approximately 400,000 people in the US ... worldwide. Add to these statistics the 2.4 percent ...
(Date:9/30/2014)... (PRWEB) September 30, 2014 ... caring individuals, National Children’s Oral Health Foundation: ... in grants to non-profit clinical partners. These ... Network and deliver comprehensive educational, preventive and ... Recipients include:,     Just Kids ...
(Date:9/30/2014)... 2014 Pivotal 5, LLC, a proven ... Life Time – The Healthy Way of Life CompanySM ... KettleWorX Group Training . KettleWorX Group Training is a ... offers consumers of all fitness levels a means to ... manner. The rollout to Life Time Athletic destinations will ...
Breaking Medicine News(10 mins):Health News:Hospice Provides Care and Support to Patients and Family Caregivers with ALS 2Health News:Dr. Edward Buckingham Approved to be Fellowship Director for Facial Plastic Surgery 2Health News:Dr. Edward Buckingham Approved to be Fellowship Director for Facial Plastic Surgery 3Health News:North American Seminars Introduces a New OT PT CME Course, Evidence Based Rehab Techniques for Parkinsons, Multiple Sclerosis and Peripheral Neuropathy 2Health News:North American Seminars Introduces a New OT PT CME Course, Evidence Based Rehab Techniques for Parkinsons, Multiple Sclerosis and Peripheral Neuropathy 3Health News:America's ToothFairy Awards More Than $150,000 in Grants to Save Young Smiles 2Health News:America's ToothFairy Awards More Than $150,000 in Grants to Save Young Smiles 3Health News:Pivotal 5 Announces Life Time Fitness As National Destination For KettleWorX Kettlebell Training 2Health News:Pivotal 5 Announces Life Time Fitness As National Destination For KettleWorX Kettlebell Training 3
... Increasing use of polyalkylimide implant injections leaves skin open ... (HealthDay News) -- Cosmetic skin fillers called polyalkylimide implant ... effects months after treatment, Spanish researchers warn. , ... used in cosmetic procedures for facial features such as ...
... for head and neck cancer may help prevent depression ... published in the May issue of Archives of OtolaryngologyHead ... Treatment for head and neck cancer can be arduous ... the article. Psychiatric morbidity in these patients is frequent ...
... as a stroke treatment, researchers say. , Minocycline appears ... white blood cells and enzymes that, at least acutely, ... Dr. David Hess, chair of the Department of Neurology ... The broad-spectrum antibiotic also seems to reduce cell suicide ...
... "World Aquaculture,2008", held on May 19-23 in Busan, ... Strathclyde, Scotland, United Kingdom, was honored with,the Intervet ... research methods in sea-lice treatments in salmon farming.,The ... of commitment to,the advancement of reducing, refining and ...
... lasting problems with memory, language, and other cognitive skills ... the surgery itself or the pump used to replace ... Hopkins researchers suggests. The findings may lead to better ... heart disease patients receive. , The study, published in ...
... May 19 The American Board of,Medical Specialties ... the United States through its 24 Member Boards,announced ... the public to,enhance physician performance assessment. Called the ... to enhance the ABMS Board,Enterprise,s role as a ...
Cached Medicine News:Health News:Cosmetic Skin Fillers May Cause Delayed Side Effects 2Health News:Medication may prevent depression in patients with head and neck cancer 2Health News:Old antibiotic may find new life as a stroke treatment 2Health News:Old antibiotic may find new life as a stroke treatment 3Health News:Prof. Dr. George Gettinby Honored With Dieter Lutticken Award 2Health News:Prof. Dr. George Gettinby Honored With Dieter Lutticken Award 3Health News:Bypass not to blame for heart patients' mental decline 2Health News:ABMS Assembly Votes in Favor of Three-Year Initiative to Enhance Public Trust in the Board Certification Process 2Health News:ABMS Assembly Votes in Favor of Three-Year Initiative to Enhance Public Trust in the Board Certification Process 3
... frustrating to a surgeon who is trying to ... instruments that are not functioning properly. Whether the ... offer a wide range of repairs for bipolar ... tips to standard or even custom insulation, Mobile ...
Only Mobile Instrument offers complete repair and rebuild capability on all makes and models of endoscopy and laparoscopy instruments, using only factory-quality parts and precision techniques....
... We repair most Olympus fiber and video ... intubation scopes used in OR and endoscopy. ... repairs meet or exceed the standards of ... a 120-day warranty against defects in materials ...
Inquire...
Medicine Products: